Fundalysisby DARKHORSESTOCKS

Stock · INE159A01016

GLAXO SMITHKLINE PHARMA

Held by 89 schemes worth ₹2,160 Cr in Sept 2026.

Schemes holding GLAXO SMITHKLINE PHARMA(Sept 2012 – Sept 2026)

Schemes holding GLAXO SMITHKLINE PHARMA in Sept 2026. Tick up to 2 to plot them.
Plot89 schemes · ₹ Cr
SBI Midcap Fund
327
Kotak Large Mid Cap Fund
305
Nippon India Pharma Fund
285
quant Mid Cap Fund
246
Nippon India Growth Mid Cap Fund
155
SBI Dividend Yield Fund
125
Tata Aggressive Hybrid Fund
69.2
quant ELSS Tax Saver Fund
48.5
Aditya Birla Sun Life MNC Fund
47.5
Helios Mid Cap Fund
46.6
Baroda BNP Paribas Mid Cap Fund
42.4
quant Healthcare Fund
41.1
Tata Business Cycle Fund
36.8
Nippon India Multi Cap Fund
32.9
Aditya Birla Sun Life Multi Cap Fund
27.7
Kotak Manufacture In India Fund
27.7
quant Multi Cap Fund
25.7
quant Dynamic Asset Allocation Fund
22.8
Helios Small Cap Fund
22.8
Helios Large Mid Cap Fund
20
Baroda BNP Paribas Dividend Yield Fund
17.5
DSP Quant Fund
14.5
Kotak ESG Exclusionary Strategy Fund
12.5
ITI Mid Cap Fund
12.4
Tata Retirement Savings Fund Progressive Plan
11.8
Tata India Pharma Healthcare Fund
11.6
Motilal Oswal Nifty Midcap 150 Index Fund
11.3
Nippon India ETF Nifty Midcap 150
10.8
Tata Retirement Savings Fund Moderate Plan
10.7
DSP Nifty Midcap 150 Qlty 50 Index Fund
10.1
SBI Quant Fund
10
Aditya Birla Sun Life Pharma Healthcare Fund
9
Nippon India Nifty Midcap 150 Index Fund
7.6
Baroda BNP Paribas Services Fund
5.5
Mirae Asset Nifty Midcap 150 ETF
5.1
Tata Nifty MidSmall Healthcare Index Fund
3.9
ICICI Prudential Nifty Midcap 150 Index Fund
3.5
SBI Nifty Midcap 150 Index Fund
3.5
ICICI Prudential Quant Fund
3.3
Baroda BNP Paribas Health and Wellness Fund
3.3
ITI Pharma and Healthcare Fund
2.6
Unifi Flexi Cap Fund
2.5
DSP Nifty Midcap 150 Quality 50 ETF
2.4
ICICI Prudential Nifty Midcap 150 ETF
2.1
HDFC Nifty Midcap 150 Index Fund
2
Motilal Oswal Nifty 500 Index Fund
1.8
ITI Multi Asset Allocation Fund
1.3
Aditya Birla Sun Life Nifty Midcap 150 Index Fund
1.3
Navi Nifty Midcap 150 Index fund
1.1
quant Equity Savings Fund
1.1
  • SBI Midcap Fund
  • Kotak Large Mid Cap Fund
Market value of GLAXO SMITHKLINE PHARMA in each ticked scheme, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.
MonthSBI Midcap FundKotak Large Mid Cap Fund
Sept 2025₹319 Cr₹293 Cr
Oct 2025₹314 Cr₹288 Cr
Nov 2025₹308 Cr₹283 Cr
Dec 2025₹297 Cr₹272 Cr
Jan 2026₹288 Cr₹264 Cr
Feb 2026₹309 Cr₹283 Cr
Mar 2026₹274 Cr₹251 Cr
Apr 2026₹280 Cr₹257 Cr
May 2026₹265 Cr₹243 Cr
Jun 2026₹294 Cr₹270 Cr
Jul 2026₹319 Cr₹292 Cr
Aug 2026₹360 Cr₹336 Cr
Sept 2026₹327 Cr₹305 Cr
Fig. 1.Market value of GLAXO SMITHKLINE PHARMA in each ticked scheme, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Allocation(Sept 2026)

Fund houses

18 fund houses% of total
Nippon
622.78
SBI
621.54
QUANT
617.85
Kotak
515.97
Tata
96.76
Helios
34.14
Aditya Birla
53.98
BNP
53.18
DSP
61.26
ITI
30.76
Other fund houses
351.79

Scheme types

Schemes

Fig. 2.What mutual funds hold of this company, by fund house, by scheme type and by scheme. Hover a slice or a row; click a slice to open it.

Schemes buying and selling GLAXO SMITHKLINE PHARMA(Oct 2025 – Sept 2026)

Schemes buying and selling GLAXO SMITHKLINE PHARMA. Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.
Fig. 3.Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.